Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Genomics BioSci & Tech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

NT$17.3

2024-10-29

Market Capitalization

NT$1.2 B

2024-10-29

Revenue

NT$708.4 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

TWDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue438.7M427.7M443.2M390.0M419.0M396.1M482.8M708.4M
Cost of goods sold249.7M228.7M248.2M246.1M250.0M236.3M297.0M401.2M
Gross profit206.8M205.7M195.7M144.9M172.0M160.5M199.5M307.7M
Gross profit margin, %48.1%44.2%37.2%41.0%40.5%41.3%43.4%
Operating expense total214.0M141.4M144.4M138.6M167.7M204.9M261.2M306.0M
Depreciation and amortization45.0M44.6M40.0M34.0M33.0M40.0M64.7M75.8M
EBITDA(7.2M)61.3M54.2M(7.1M)(14.3M)(64.0M)(114.4M)1.7M
EBITDA margin, %14.3%12.2%-1.8%-3.4%-16.1%-23.7%0.2%
EBIT(65.8M)(82.9M)10.2M25.4M75.0M(116.3M)(219.3M)(46.5M)
EBIT margin, %-19.4%2.3%6.5%17.9%-29.4%-45.4%-6.6%
Interest income1.6M1.2M265.0K353.0K2.1M2.4M2.1M
Interest expense1.1M1.1M998.0K1.7M2.0M4.8M9.7M14.8M
Pre tax profit(67.4M)12.9M(3.1M)12.1M72.3M(167.9M)(235.3M)(67.6M)
Income tax expense814.0K4.4M(1.7M)664.0K125.0K
Net Income(68.2M)8.4M(1.5M)12.1M71.6M(168.1M)(235.3M)(67.6M)

Footer menu